CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 118(Granted Patents)

Location History:

Settsu, JP (2006 - 2008)
Kobe, JP (1987 - 2014)
Hyogo, JP (2021)

Company Filing History:

Kanegafuchi Kagaku Kogyo Kabushiki Kaisha

patents

Years Active: 1987-2021

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11156598 - Method for evaluating content of mesenchymal stem cells in cell-containing sample (2021-10-26),

2. 8785141 - Bacterial toxin adsorbing material, method of removing the toxin by adsorbing, and an adsorber formed by filling the adsorbing material therein (2014-07-22),

3. 7348294 - Adsorbent and method for adsorbing cardiac glycoside (2008-03-25),

4. 7320757 - Body fluid processor enabling direct hemoperfusion (2008-01-22),

5. 7309488 - Adsorbents for dilated cardiomyopathy (2007-12-18),

6. 7279106 - Adsorbent and method for adsorbing a chemokine in body fluid (2007-10-09),

7. 7153945 - Peptide, novel adsorbent, adsorption unit and adsorption method (2006-12-26),

8. 6969616 - Enterotoxin adsorbent, method of adsorptive removal, and adsorption apparatus (2005-11-29),

9. 6951644 - Adsorbent for peptidoglycan and method and apparatus for adsorptively removing peptidoglycan (2005-10-04),

10. 6878269 - Device for body fluid purification and system for body fluid purification (2005-04-12),

11. 6844427 - Method for removing the transforming growth factor-β by adsorption (2005-01-18),

12. 6790365 - Process for adsorbing and removing endogenous cannabinoid (2004-09-14),

13. 6559290 - Method for removing a chemokine (2003-05-06),

14. 6475478 - Adsorbent, adsorbing and removing process and adsorber for endogenous cannabinoid (2002-11-05),

15. 5919898 - Absorbent for removing interleukins and tumor necrosis factor, and (1999-07-06),

Title: Shigeo Furuyoshi: Innovator and Patent Holder in Biomedical Technologies

Introduction

Shigeo Furuyoshi, a distinguished inventor based in Kobe, Japan, has made significant contributions to the field of biomedical technologies. With a remarkable tally of 20 patents to his name, Furuyoshi has been at the forefront of innovations that enhance our understanding and capabilities in medical science.

Latest Patents

Among his most recent patents is a pioneering method for evaluating the content of mesenchymal stem cells in cell-containing samples. This method involves the detection of a nucleotide sequence in genomic DNA, which allows for the precise evaluation of mesenchymal stem cell content derived from adipose tissue or related cell-containing fractions. This innovative approach includes targeting specific CpG sites, contributing to advancements in regenerative medicine.

Another notable invention by Furuyoshi is an adsorbent for bacterial toxins, along with a method for their removal through adsorption. His design includes an adsorber packed with this specialized adsorbent, which aims to tackle bacterial toxins effectively. This invention is crucial for applications in medical settings where such toxins pose significant health risks.

Career Highlights

Shigeo Furuyoshi has had an impactful career with key roles in prominent companies, notably Kaneka Corporation and Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. His involvement in these organizations has allowed him to apply his innovative ideas and collaborate with leading experts in the field.

Collaborations

Throughout his career, Furuyoshi has collaborated with esteemed colleagues such as Fumiyasu Hirai and Masaru Nakatani. These partnerships have led to joint efforts in research and development, further advancing the boundaries of biomedical technology and innovation.

Conclusion

Shigeo Furuyoshi's contributions to the field of biomedical technologies, highlighted by his substantial patent portfolio, reflect his dedication to innovation. His work not only enhances our understanding of stem cell biology but also offers practical solutions for healthcare challenges. As he continues to push the envelope of what's possible in biomedical research, his impact on the industry remains significant and inspiring.

This text is generated by artificial intelligence and may not be accurate.